Lifecore Biomedical (LFCR) Competitors $6.45 -0.18 (-2.71%) Closing price 04:00 PM EasternExtended Trading$6.45 0.00 (0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LFCR vs. WVE, GYRE, PAHC, MLYS, COLL, SNDX, RCUS, ELVN, AVDL, and SYREShould you be buying Lifecore Biomedical stock or one of its competitors? The main competitors of Lifecore Biomedical include Wave Life Sciences (WVE), Gyre Therapeutics (GYRE), Phibro Animal Health (PAHC), Mineralys Therapeutics (MLYS), Collegium Pharmaceutical (COLL), Syndax Pharmaceuticals (SNDX), Arcus Biosciences (RCUS), Enliven Therapeutics (ELVN), Avadel Pharmaceuticals (AVDL), and Spyre Therapeutics (SYRE). These companies are all part of the "pharmaceutical products" industry. Lifecore Biomedical vs. Wave Life Sciences Gyre Therapeutics Phibro Animal Health Mineralys Therapeutics Collegium Pharmaceutical Syndax Pharmaceuticals Arcus Biosciences Enliven Therapeutics Avadel Pharmaceuticals Spyre Therapeutics Wave Life Sciences (NASDAQ:WVE) and Lifecore Biomedical (NASDAQ:LFCR) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, community ranking, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends. Do insiders & institutionals believe in WVE or LFCR? 89.7% of Wave Life Sciences shares are held by institutional investors. Comparatively, 83.4% of Lifecore Biomedical shares are held by institutional investors. 29.1% of Wave Life Sciences shares are held by company insiders. Comparatively, 32.2% of Lifecore Biomedical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has better earnings and valuation, WVE or LFCR? Lifecore Biomedical has higher revenue and earnings than Wave Life Sciences. Wave Life Sciences is trading at a lower price-to-earnings ratio than Lifecore Biomedical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWave Life Sciences$104.94M8.87-$57.51M-$0.84-7.19Lifecore Biomedical$130.31M1.83$12.01M-$1.45-4.45 Do analysts prefer WVE or LFCR? Wave Life Sciences presently has a consensus target price of $21.17, indicating a potential upside of 250.44%. Lifecore Biomedical has a consensus target price of $8.00, indicating a potential upside of 24.03%. Given Wave Life Sciences' stronger consensus rating and higher possible upside, research analysts plainly believe Wave Life Sciences is more favorable than Lifecore Biomedical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wave Life Sciences 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.00Lifecore Biomedical 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has more risk and volatility, WVE or LFCR? Wave Life Sciences has a beta of -0.92, suggesting that its share price is 192% less volatile than the S&P 500. Comparatively, Lifecore Biomedical has a beta of 0.65, suggesting that its share price is 35% less volatile than the S&P 500. Does the media refer more to WVE or LFCR? In the previous week, Wave Life Sciences had 8 more articles in the media than Lifecore Biomedical. MarketBeat recorded 13 mentions for Wave Life Sciences and 5 mentions for Lifecore Biomedical. Wave Life Sciences' average media sentiment score of 1.15 beat Lifecore Biomedical's score of 0.45 indicating that Wave Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Wave Life Sciences 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lifecore Biomedical 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community prefer WVE or LFCR? Wave Life Sciences received 364 more outperform votes than Lifecore Biomedical when rated by MarketBeat users. Likewise, 67.77% of users gave Wave Life Sciences an outperform vote while only 30.77% of users gave Lifecore Biomedical an outperform vote. CompanyUnderperformOutperformWave Life SciencesOutperform Votes36867.77% Underperform Votes17532.23% Lifecore BiomedicalOutperform Votes430.77% Underperform Votes969.23% Is WVE or LFCR more profitable? Lifecore Biomedical has a net margin of -12.52% compared to Wave Life Sciences' net margin of -66.50%. Wave Life Sciences' return on equity of -280.57% beat Lifecore Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Wave Life Sciences-66.50% -280.57% -52.90% Lifecore Biomedical -12.52%-315.23%-12.74% SummaryWave Life Sciences beats Lifecore Biomedical on 13 of the 19 factors compared between the two stocks. Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFCR vs. The Competition Export to ExcelMetricLifecore BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$238.81M$6.48B$5.35B$8.38BDividend YieldN/A2.66%5.22%4.10%P/E Ratio-11.528.9226.8419.71Price / Sales1.83250.96391.39116.98Price / CashN/A65.8538.2534.62Price / Book17.436.466.794.50Net Income$12.01M$143.98M$3.23B$248.18M7 Day Performance-3.30%3.04%4.07%1.14%1 Month Performance6.79%7.44%12.52%15.20%1 Year Performance8.22%-2.46%16.83%6.56% Lifecore Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFCRLifecore Biomedical1.2466 of 5 stars$6.45-2.7%$8.00+24.0%+11.7%$238.81M$130.31M-11.52690Analyst ForecastWVEWave Life Sciences4.3682 of 5 stars$6.60+0.2%$21.17+220.7%+2.5%$1.02B$108.30M-5.95240Positive NewsGap DownGYREGyre Therapeutics0.2757 of 5 stars$10.83+13.6%N/A-21.0%$1.02B$105.76M541.5040PAHCPhibro Animal Health3.5371 of 5 stars$24.50+9.0%$20.00-18.4%+32.1%$992.32M$1.11B51.041,860Positive NewsMLYSMineralys Therapeutics2.7745 of 5 stars$15.01+2.5%$33.00+119.9%+25.7%$973.79MN/A-4.1228Gap DownCOLLCollegium Pharmaceutical4.0712 of 5 stars$29.56+2.3%$43.80+48.2%-12.3%$949.82M$631.45M12.74210News CoveragePositive NewsSNDXSyndax Pharmaceuticals3.8418 of 5 stars$10.99+2.7%$35.91+226.7%-47.8%$945.66M$43.72M-3.03110Positive NewsRCUSArcus Biosciences3.554 of 5 stars$8.82+6.5%$25.67+191.2%-47.4%$933.38M$141M-2.80500Positive NewsHigh Trading VolumeELVNEnliven Therapeutics2.5053 of 5 stars$19.01+3.2%$40.33+112.2%-27.6%$932.75MN/A-10.0150Earnings ReportAnalyst RevisionGap UpAVDLAvadel Pharmaceuticals2.2288 of 5 stars$9.59+2.1%$19.43+102.6%-40.3%$926.67M$169.12M-12.1470SYRESpyre Therapeutics2.3372 of 5 stars$14.93+5.9%$51.17+242.7%-58.2%$899.92M$890,000.00-2.00100Positive NewsGap Down Related Companies and Tools Related Companies Wave Life Sciences Competitors Gyre Therapeutics Competitors Phibro Animal Health Competitors Mineralys Therapeutics Competitors Collegium Pharmaceutical Competitors Syndax Pharmaceuticals Competitors Arcus Biosciences Competitors Enliven Therapeutics Competitors Avadel Pharmaceuticals Competitors Spyre Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFCR) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifecore Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LFCR Stock Free LFCR Stock Alerts